Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Acceleron Pharma, Inc. - Celgene Corporation and Acceleron Pharma Initiate Phase 2 Study of ACE-011 in Patients with Multiple Myeloma
Ardea Biosciences, Inc. - Ardea Biosciences Initiates a Phase 1/2 Study of RDEA119, its Lead MEK Inhibitor, in Combination with Nexavar sorafenib in Patients with Advanced Cancer
Genzyme Corporation - Study Results: Multiple Sclerosis Patients Have Significant and Sustained Reduction in Disability and Risk of Relapse On Alemtuzumab Versus Approved Therapy, Rebif
Transcept Pharmaceuticals, Inc. - Clinical Study of Intermezzo(R) for the Treatment of Middle of the Night Awakening Published in SLEEP
Trius Therapeutics, Inc. - Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA
Anthrax Vaccines - New anthrax vaccines study findings recently were reported by N. Marano and co-researchers
Cancer Vaccines - Studies from M. Barve and colleagues reveal new findings on cancer vaccines
Dermatology - Reports from University of Miami, Medical Department add new data to research in dermatology
DNA Vaccines - Data on DNA vaccines discussed by researchers at University of Colorado
Drug Resistance - New drug resistance study findings recently were published by I. Florescu and co-researchers
Herpesvirus - Researchers from University of Washington detail findings in herpesvirus
HIV/AIDS - Research from R.M. Gulick and co-authors in the area of HIV/AIDS published
Life Sciences - Research data from J.C. Jimenez and colleagues update understanding of life sciences
Non-Hodgkin Lymphoma - Researchers from Georgetown University publish findings in non-hodgkin lymphoma
Pneumonia - New research on pneumonia from K. Vasilev and co-authors summarized
Rectal Cancer - Recent findings from Schleswig-Holstein University highlight research in rectal cancer
Enzyme Research - Researchers from Bayer Healthcare report details of new studies and findings in the area of enzyme research
HIV/AIDS Therapy - New HIV/AIDS therapy study findings recently were published by investigators at Schering Plough Research Institute
Lymphoma Therapy - Investigators at Abbott Laboratories release new data on lymphoma therapy
Pharmacodynamics - New pharmacodynamics study findings recently were reported by researchers at Tokyo Medical University, First Department of Internal Medicine
Pharmacokinetics - Reports outline pharmacokinetics study results from M. Schöller-Gyüre et al
Pharmacology - New pharmacology data have been reported by scientists at Medicines and Healthcare products Regulatory Agency
Acne Vulgaris - Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase II/III Acne Scar Study
Alzheimer Disease - GlaxoSmithKline and AFFiRiS Sign an Exclusive Licence and Option Agreement for Therapeutic Alzheimer's Disease Candidate Vaccines
Anti-Infectives - Nektar Sells Pulmonary Business to Novartis for $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
Aradigm Corporation - Aradigm Presents Phase 2 Data on Inhaled Liposomal Ciprofloxacin in Cystic Fibrosis at the North American Cystic Fibrosis Conference
ARIAD Pharmaceuticals, Inc. - Ariad Announces Start of Phase 2 Clinical Study of Oral Deforolimus in Patients with Prostate Cancer
ARIAD Pharmaceuticals, Inc. - ARIAD Presents Preclinical Data on Deforolimus and Bicalutamide in Androgen-Independent Prostate Cancer
Biotech Business - Qualia Clinical Services Chooses ALPHADAS(R) for Phase I Clinical Trials
Breast Cancer - Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer
Cancer - Local Research Foundation Achieves Milestone in Fight Against Cancer
Cancer - Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting
Cancer - Positive Preclinical Data Demonstrating Anti-Tumor Activity of NKTR-105 (PEG-docetaxel) Presented at 20th EORTC-NCI-AACR Conference
Cancer - Preliminary Clinical Data Presented at the 20th EORTC-NCI-ACR Symposium on 'Molecular Targets and Cancer Therapeutics' Demonstrate Superior Profile of S*BIO's Novel Anti-Cancer Drug SB939
Cancer - SuperGen's MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy
Candidiasis - TorreyPines Therapeutics Begins Dosing in a Phase I Multiple Dose Clinical Trial of NGX426, Oral Prodrug of Tezampanel
Cell Genesys, Inc. - Cell Genesys Announces Termination of VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer Based on Outcome of Futility Analysis and Reports Preliminary Analysis of VITAL-2 Trial Results
Clinical Trial Research - Glycotex Reports First Patient Enrollment in Phase IIb Study of Lead Product Candidate GLYC-101 for Wound Healing
Constipation - New Data Confirm Consistent Efficacy and Favourable Safety Profile of Resolor(R) (Prucalopride) for Patients With Severe Chronic Constipation
Cougar Biotechnology, Inc. - Cougar Biotechnology Presents Positive CB7630 Phase II Data at EORTC-NCI-AACR Symposium
Cytochroma - Cytochroma announces initiation of Phase II clinical trial of CTA018 for chronic kidney disease patients
Depomed, Inc. - Depomed Initiates Second Phase 3 Trial in Menopausal Hot Flashes
Diabetes - Phenomix and Forest Laboratories to Collaborate on Development and Commercialization of Dutogliptin in Diabetes
Exelixis, Inc. - Exelixis Reports Positive Phase 1 Data for PI3K Inhibitor XL147 at EORTC-NCI-AACR Symposium
Exelixis, Inc. - Exelixis Reports Positive Phase 1 Data for XL281 at EORTC-NCI-AACR Symposium
Exelixis, Inc. - Exelixis Retains Rights to Develop and Commercialize XL184
Geron Corporation - Geron Initiates Clinical Trial of GRN163L in Combination With Bortezomib and Dexamethasone in Patients With Multiple Myeloma
Halsin Partners - AngioChem's ANG1005 demonstrates preliminary clinical safety and tolerability in brain cancers
HIV/AIDS - GeoVax's DNA and MVA Vaccines Shipped to HIV Vaccine Trials Network for Use in the Upcoming Phase 2a Trial
HIV/AIDS - U.S. Food and Drug Administration (FDA) Approves PREZISTA(R) Once-Daily as Part of Combination Therapy for Treatment-Naive Adults with HIV-1
Hypertension - Addrenex Pharmaceuticals Initiates Phase 2 Trial on Its Novel Hypertension Drug, ADX415
Hypertension - Aires Pharmaceuticals Signs Key Technology License Agreement With the National Institutes of Health
Ichor Medical Systems - Preliminary Phase I Safety Data for Preventive HIV Vaccine Delivered by Ichor's TriGrid to be Presented at AIDS Conference
Influenza - Peramivir Phase 2 Data for the Treatment of Outpatient Influenza to be Presented at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Living Cell Technologies Limited - Living Cell Technologies Receives Health Minister's Approval to Start Leading Edge Live Cell Therapy Clinical Trial in New Zealand for Diabetics
Logos Technologies - Qualia Clinical Services Chooses ALPHADAS for Phase I Clinical Trials
Maxygen, Inc. - Maxygen Announces Plans to Reduce Spending and Revise Corporate Strategy
Movetis Nv - New Data Confirm Consistent Efficacy and Favourable Safety Profile of Resolor Prucalopride for Patients With Severe Chronic Constipation
NewsRx - NewsRx Launches Asia, China, India Titles; Offers Free Global Warming Publication
Pediatrics - PTC Announces Data Showing That PTC124 Causes Statistically Significant Improvements in Chloride Channel Function in Cystic Fibrosis Patients
Pharmacokinetics - Significant Anti-Tumor Activity and Extended Half-Life of NKTR-102 (PEG-irinotecan) Highlighted in Phase 1 Data Presented at EORTC-NCI-AACR Symposium
Phoenix Biotechnology, Inc. - Despite Tight Financial Market, Company with Anti-Cancer Drug in Clinical Trial Raises $3.6 Million in Private Placement
Prostate Cancer - Medivation Announces Presentation of 24-Week Clinical Data of MDV3100 in Castration-Resistant Prostate Cancer Patients
S*BIO Pte Ltd - S*BIO Completes US$26 Million Equity Financing
Saint Louis University - Research identifies type of vaccine that holds promise in protecting against TB
Sciele Pharma, Inc. - Sciele Pharma Announces That Addrenex Pharmaceuticals Initiates Phase II Clinical Trial of ADX415 for the Treatment of Hypertension
Solid Cancer - Chipscreen Biosciences and HUYA Bioscience Int'l Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer
Solid Cancer - Proteolix Presents Solid Tumor Clinical Trial Results for Carfilzomib at EORTC-NCI-AACR International Conference
Targanta Therapeutics Corporation - Targanta Therapeutics Releases Results from Phase 2 SIMPLIFI Study Evaluating Single or Infrequent Doses of Oritavancin
ZIOPHARM Oncology, Inc. - ZIOPHARM Presents Darinaparsin Molecular Mechanism of Action and Preliminary Oral Administration Phase I Clinical Data at the EORTC-NCI-AACR Symposium
ZymoGenetics, Inc. - ZymoGenetics Presents Interim IL-21 Phase 2 Results in Renal Cell Cancer
